91短视频永久免费版app下载-91短视频在线高清hd-91短视频在线观看-91粉嫩萝-91粉嫩萝控精品福利网站免费观看视频-91福利

The first generic drug consistency evaluation in China

- A new generation of selective ergot dopamine receptor agonists;

- It is recommended as first-line medication for early Parkinson’s treatment by the United States, European and Chinese Parkinson's guidelines.

- Its efficacy and safety are demonstrated by over-20-year clinical medication experience abroad.

- The incidence of dyskinesia in early Parkinson's patients is very low, and it can significantly delay the onset of dyskinesia.

-It assists L-dopa in the treatment of patients with advanced Parkinson’s disease. It can effectively shorten the “day off phenomenon” and reduce 20% of the usage amount of L-dopa.